BacLite Rapid MRSA Clinical Performance

This study has been terminated.

( performance variability )

First Received: October 6, 2007 Last Updated: May 14, 2008 History of Changes

Sponsored by:	3M
Information provided by:	3M
ClinicalTrials.gov Identifier:	NCT00541632

Purpose

The purpose of this study is to compare the performance of the 3M(TM) BacLite (TM) Rapid MRSA test system to traditional culture methods in detecting the presence of Methicillin Resistant Staphylococcus aureus (MRSA) directly from nasal samples.

Condition
Methicillin Resistance

Study Type:	Observational
Study Design:	Prospective
Official Title:	BacLite Rapid MRSA Clinical Performance

Further study details as provided by 3M:

Study Start Date:	October 2007
Study Completion Date:	March 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Subjects 18 years or older
Subjects willing to document demographic characteristics
Subjects willing to have their nose swabbed
Subjects (or legal representative) willing to sign consent and authorization forms

Exclusion Criteria:

Subjects who use Vicks Sinex Nasal spray or other nasal sprays
Subjects with prescribed nasal medical devices where collecting samples may resent more than minimal risk to subjects
Subjects having nasal prosthetics, jewelry or trauma to the nose or anything that may prevents sampling the anterior nares
Investigator believes that subject is unsuitable for inclusion.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541632

Locations

United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
United States, Georgia
Atlanta Institute for Medical Research, Inc.
Atlanta, Georgia, United States, 30030
United States, Illinois
Evanston Northwestern Healthcare
Evanston, Illinois, United States, 60201
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201-1595
United States, Michigan
Wayne State University
Detroit, Michigan, United States, 48201
United States, Missouri
Washington University
St. Louis, Missouri, United States, 63110
United States, North Carolina
Wake Forest University
Winston-Salem, North Carolina, United States, 27157-1042
United States, Ohio
Cleveland Clinic
Cleveland, Ohio, United States, 44195

Sponsors and Collaborators

Investigators

Principal Investigator:

Werner E Bischoff

Wake Forest University

More Information

No publications provided

Study ID Numbers:	010737
Study First Received:	October 6, 2007
Last Updated:	May 14, 2008
ClinicalTrials.gov Identifier:	NCT00541632 History of Changes
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on August 28, 2009